Fact check · Version 1 · Sources checked
“Cerebrolysin has been studied in randomized human trials.”
The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.
Supported with scope
The reviewed evidence supports this exact statement only in the situation described below.
Yes. CASTA and other randomized studies tested the named product in defined groups and settings. The existence of these studies does not prove a benefit for every outcome or product.
- What this answer is based on
- This answer uses a study that assigned people to groups by chance and measured a health outcome.
- Limits of this answer
- The exact Cerebrolysin product, study group, comparison, outcome, and follow-up period in each randomized trial. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.
- Topic
- What a study measured about people's health, symptoms, or ability to function.
Sources for this fact check
Show 3 sources
01CASTA randomized acute stroke trialPubMed · Stroke · Randomized trial · 201202Cochrane review of Cerebrolysin for acute ischemic strokePubMed · Cochrane Database of Systematic Reviews · Science review · 202303Cochrane review of Cerebrolysin for vascular dementiaPubMed · Cochrane Database of Systematic Reviews · Science review · 2019
- Sources checked by
- Site editor · Editorial review